Factors Associated with RANTES Concentration in Cardiovascular Disease Patients.

Olga Martyna Koper-LenkiewiczJoanna KamińskaAnna LisowskaAnna MilewskaTomasz HirnleVioletta Joanna Dymicka-Piekarska

Published in: BioMed research international (2019)

Due to high variability of obtained CCL2 concentrations, it seems that RANTES better reflects the presence of the atherosclerotic lesion than CCL2. RANTES as a marker of atherosclerotic process may be an important therapeutic target, and the assessment of RANTES concentration should be interpreted depending on patient's sex, age, platelet hyperactivity state, hsCRP, and CCL2 concentration.

Keyphrases

cardiovascular disease
liver fibrosis
liver injury
end stage renal disease
ejection fraction
newly diagnosed
case report
peritoneal dialysis
metabolic syndrome
cardiovascular events